Publicaties

2022

  • Bharadia, T., Vandercappellen, J., Chitnis, T., Eelen, P., Bauer, B., Brichetto, G., Lloyd, A., Schmidt, H., King, M., Fitzgerald, J., Hach, T., & Hobart, J. (2022). Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables?. Multiple sclerosis journal - experimental, translational and clinical, 8(2), 20552173221105642. https://doi.org/10.1177/20552173221105642
     
  • Borragán, G., Benoit, C. E., Schul, N., Strauss, M., De Schepper, M., Roekens, V., & Peigneux, P. (2022). Impaired Sequential but Preserved Motor Memory Consolidation in Multiple Sclerosis Disease. Neuroscience, 487, 99–106. https://doi.org/10.1016/j.neuroscience.2021.12.029
     
  • Brichetto G., Tacchino A., Leocani L., Kos D. (2022). Impact of Covid-19 emergency on rehabilitation services for Multiple Sclerosis: An international RIMS survey, Multiple Sclerosis and Related Disorders, 67,2022, 104179, https://doi.org/10.1016/j.msard.2022.104179.
     
  • De Coninck L., Peeters N. Ouderen kunnen na een heupfractuur langer thuis blijven wonen met een uitgebreid oefenprogramma? (2022) Minerva duiding, Tijdschrift voor Evidence-Based Medicine, 21(4), 87 – 90. www.minerva-ebm.be/NL/Article/2259
     
  • Denissen, S., Engemann, D. A., De Cock, A., Costers, L., Baijot, J., Laton, J., Penner, I. K., Grothe, M., Kirsch, M., D'hooghe, M. B., D'Haeseleer, M., Dive, D., De Mey, J., Van Schependom, J., Sima, D. M., & Nagels, G. (2022). Brain age as a surrogate marker for cognitive performance in multiple sclerosis. European journal of neurology, 29(10), 3039–3049. https://doi.org/10.1111/ene.15473
     
  • Jansa, J., Ferdinand, S., Milo, M., Løyning, I. G., Huilla, T., Kallmayer, L., Ilsbroukx, S., Filló, N., Raats, J., Jakobson, J., & Kos, D. (2022). Performance of Activities of daily living in people with multiple sclerosis. Multiple sclerosis and related disorders, 57, 103342. https://doi.org/10.1016/j.msard.2021.103342
     
  • Kahraman, T., Rasova, K., Jonsdottir, J., Medina, C. S., Kos, D., Coote, S., Tacchino, A., Smedal, T., Arntzen, E. C., Quinn, G., Learmonth, Y., Pedulla, L., Moumdjian, L., & Kalron, A. (2022). The impact of the COVID-19 pandemic on physical therapy practice for people with multiple sclerosis: A multicenter survey study of the RIMS network. Multiple sclerosis and related disorders, 62, 103799. Advance online publication. https://doi.org/10.1016/j.msard.2022.103799
     
  • Kos D. Aangepaste en uitgebreide ondersteunende technologie en telezorg effectief om personen met dementie langer en veiliger thuis te laten wonen? (2022) Minerva duiding, Tijdschrift voor Evidence-Based Medicine, 21(2), 39 – 42. www.minerva-ebm.be/NL/Article/2248
     
  • Moumdjian L, Smedal T, Arntzen EC, van der Linden ML, Learmonth Y, Pedullà L, Tacchino A, Novotna K, Kalron A, Yazgan YZ, Nedeljkovic U, Kos D, Jonsdottir J, Santoyo-Medina C, Coote S. Impact of the COVID-19 Pandemic on Physical Activity and Associated Technology Use in Persons With Multiple Sclerosis: An International RIMS-SIG Mobility Survey Study. Arch Phys Med Rehabil. 2022 Jun 26:S0003-9993(22)00478-6. doi: 10.1016/j.apmr.2022.06.001. Epub ahead of print.
     
  • Moumdjian, L., Six, J., Veldkamp, R., Geys, J., Van Der Linden, C., Goetschalckx, M., Van Nieuwenhoven, J., Bosmans, I., Leman, M., & Feys, P. (2022). Embodied learning in multiple sclerosis using melodic, sound, and visual feedback: a potential rehabilitation approach. Annals of the New York Academy of Sciences, 1513(1), 153–169. https://doi.org/10.1111/nyas.14777
     
  • Pauwels, A., Van Schependom, J., Devolder, L., Van Remoortel, A., Nagels, G., Bjerke, M., & D'hooghe, M. B. (2022). Plasma glial fibrillary acidic protein and neurofilament light chain in relation to disability worsening in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 28(11), 1685–1696. https://doi.org/10.1177/13524585221094224
     
  • Sadeghi, N., Eelen, P., Nagels, G., Cuvelier, C., Van Gils, K., D'hooghe, M. B., Van Schependom, J., & D'haeseleer, M. (2022). Innovating Care in Multiple Sclerosis: Feasibility of Synchronous Internet-Based Teleconsultation for Longitudinal Clinical Monitoring. Journal of personalized medicine, 12(3), 433. https://doi.org/10.3390/jpm12030433
     
  • Temmerman, J., Van Der Veken, F., Engelborghs, S., Guldolf, K., Nagels, G., Smeets, D., Allemeersch, G. J., Costers, L., D'hooghe, M. B., Vanbinst, A. M., Van Schependom, J., Bjerke, M., & D'haeseleer, M. (2022). Brain Volume Loss Can Occur at the Rate of Normal Aging in Patients with Multiple Sclerosis Who Are Free from Disease Activity. Journal of clinical medicine, 11(3), 523. https://doi.org/10.3390/jcm11030523
     
  • Van Laethem D, Van de Steen F, Kos D, Naeyaert M, Van Schuerbeek P, D’Haeseleer M, D’Hooghe MB, Van Schependom J, Nagels G. Cognitive-motor telerehabilitation in multiple sclerosis (CoMoTeMS): study protocol for a randomised controlled trial. Trials. 2022 Dec;23(1):1-0. 10.1186/s13063-022-06697-9
     
  • Van Laethem, D., De Cock, A., Van Schependom, J., Benedict, R., Nagels, G., & D'hooghe, M. (2022). Correlates of patient-reported cognitive performance with regard to disability. Scientific reports, 12(1), 13489. https://doi.org/10.1038/s41598-022-17649-3
     
  • Veldkamp, R., Moumdjian, L., van Dun, K., Six, J., Vanbeylen, A., Kos, D., & Feys, P. (2022). Motor sequence learning in a goal-directed stepping task in persons with multiple sclerosis: a pilot study. Annals of the New York Academy of Sciences, 1508(1), 155–171. https://doi.org/10.1111/nyas.14702
     

2021

Jansa J, Ferdinand S, Milo M, Løyning IG, Huilla T, Kallmayer L, Ilsbroukx S, Filló N, Raats J, Jakobson J, Kos D.

Multiple Sclerosis and Related Disorders, October 20, 2021.
doi:10.1016/j.msard.2021.103342

 

Veldkamp, R., Moumdjian, L., van Dun, K., Six, J., Vanbeylen, A., Kos, D. and Feys, P.

Annals of the New York Academy of Sciences, October 2021.
doi: 10.1111/nyas.14702

 

Baijot J, Denissen S, Costers L, Gielen J, Cambron M, D'Haeseleer M, D'hooghe MB, Vanbinst AM, De Mey J, Nagels G, Van Schependom J.

Sci Rep. 2021, 11(1):7376

doi: 10.1038/s41598-021-86792-0

 

Veldkamp R, Kalron A, Baert I, Hämäläinen P, Tacchino A, D'hooge M, Giffroy X, Van Geel F, Raats J, Coninx K, Van Wijmeersch B, Feys P.

Multiple Sclerosis, 2021, 27(12):1924-1938.
doi: 10.1177/1352458520986960. Epub 2021 Feb 10. PMID: 33565906

 

White S, Harris C, Allan M, Chieffe C, Eelen P, Röder C, Mouzawak C, Naylor ML.

Neurol Ther. 2021 Jun;10(1):251-263
doi: 10.1007/s40120-021-00238-3

 

Verduyn C, Bjerke M, Duerinck J, Engelborghs S, Peers K, Versijpt J, D'haeseleer M.

Neurology. 2021 Apr 13;96(15):705-715
doi: 10.1212/WNL.0000000000011750

 

Van Schependom J., Vidaurre D., Costers L., Sjøgård M., Sima DM, Smeets D, D'hooghe MB, D'haeseleer M., Deco G, Wens V, De Tiège X, Goldman S, Woolrich M, & Nagels G.

Neuroimage Clinical, 2021;30:102632
doi:10.1016/j.nicl.2021.102632

 

Van Geel F, Bielen H, Theunissen K, Moumdjian L, Van Nieuwenhoven J, Van Wijmeersch B, Meesen R, Ramari C, Feys P.

Int J Rehabil Res., 2021,44(2):118-125
doi: 10.1097/MRR.0000000000000457

 

Sjøgård M, Wens V, Van Schependom J, Costers L, D'hooghe M, D'haeseleer M, Woolrich M, Goldman S, Nagels G, De Tiège X.

Hum Brain Mapp. 2021 Feb 15;42(3):626-643.

doi: 10.1002/hbm.25247.

 

D’hooghe MB, Willekens B, Delvaux V, D’haeseleer M, Guillaume D, Laureys G, Nagels G, Vanderdonckt P, Van Pesch V, Popescu V.

BMC Neurol, 2021, 21, 227
doi:10.1186/s12883-021-02246-0

 

Noë S, Goeleven A, Brouwers H, Meurrens T, De Cock A, Kos D, Vanhaecht K.

Int J MS Care 2021, 23 (5): 223–228
doi: 10.7224/1537-2073.2020-019

 

Costers L, Van Schependom J, Laton J, Baijot J, Sjøgård M, Wens V, De Tiège X, Goldman S, D'Haeseleer M, D'hooghe MB, Woolrich M, Nagels G.

Hum Brain Mapp, 2021;42(5):1376-1390.

doi: 10.1002/hbm.25299. Epub 2020 Nov 28.

 

2020

Peeters N, Løyning IG, Ferdinand S, Kos D.

Int J MS Care. 2020 Nov-Dec;22(6):256-262.

doi: 10.7224/1537-2073.2019-094. Epub 2020 Oct 16.

 

Hostenbach S, Raeymaekers H, Van Schuerbeek P, Vanbinst AM, Cools W, De Keyser J, D'Haeseleer M.

Front Neurol. 2020, Jul 14;11:674.
doi: 10.3389/fneur.2020.00674.

 

Pannek J, Everaert K, Möhr S, Vance W, Van der Aa F, Kesselring J.

BMC Urol., 2020, 20(1):92.
doi: 10.1186/s12894-020-00650-1.

 

Devogelaere J, D'hooghe MB, Vanderhauwaert F, D'haeseleer M.

Neurol Sci. 2020, 41(8):1981-1983.
doi: 10.1007/s10072-020-04522-2.

 

Butzkueven H, Kappos L, Wiendl H, Trojano M, Spelman T, Chang I, Kasliwal R, Jaitly S, Campbell N, Ho PR, Licata S; Tysabri Observational Program (TOP) Investigators. (TOP: D'Hooghe MB, D’haeseleer M)

J Neurol Neurosurg Psychiatry. 2020 Jun;91(6):660-668.

doi: 10.1136/jnnp-2019-322326. Epub 2020 Mar 31.

 

Tacchino A, Veldkamp R, Coninx K, Brulmans J, Palmaers S, Hämäläinen P, D'hooge M, Vanzeir E, Kalron A, Brichetto G, Feys P, Baert I.

JMIR Mhealth Uhealth. 2020 Apr 16;8(4):e15344.

doi: 10.2196/15344. PMID: 32343258; PMCID: PMC7218603.

 

Grothe M, Domin M, Hoffeld K, Nagels G, Lotze M.

Mult Scler Relat Disord, 2020,43:102159
doi: 10.1016/j.msard.2020.102159. Epub 2020 May 12.

 

Schiffmann I, Freund M, Vettorazzi E, Stellmann JP, Heyer-Borchelt S, D'Hooghe MB, Häußler V, Rahn AC, Heesen C.

Trials, 2020, 21, 1008
doi: https://doi.org/10.1186/s13063-020-04855-5

 

Kos D, Ferdinand S, Duportail M, Eijssen I, Schouteden S, Kerkhofs L, Jansa J, Fillo N, Matuska K, Beckerman H.

Multiple Sclerosis and Related Disorders,Volume 39, 2020, 101879, ISSN 2211-0348

doi: doi.org/10.1016/j.msard.2019.101879

 

D'Haeseleer M, Eelen P, Sadeghi N, D'Hooghe MB, Van Schependom J, Nagels G.

J Med Internet Res. 2020 May 20.

doi: 10.2196/18178. Epub ahead of print. PMID: 32447274.

 

Costers L, Van Schependom J, Laton J, Baijot J, Sjøgård M, Wens V, De Tiège X, Goldman S, D'Haeseleer M, D'hooghe MB, Woolrich M, Nagels G.

Hum Brain Mapp. 2020 Mar 17. doi: 10.1002/hbm.24955.

 

Reynders T*, Devolder L*, Valles-Colomer M, Van Remoortel A, Joossens M, De Keyser J, Nagels G, D'hooghe M*, Raes J* (* joint first and last authorship)

Ann Clin Transl Neurol. 2020 Mar 12.
doi: 10.1002/acn3.51004.

 

Goudman L, Marinazzo D, Van de Steen F, Nagels G, De Smedt A, Huysmans E, Putman K, Buyl R, Ickmans K, Nijs J, Coppieters I, Moens M.

Brain Res. 2020 Apr 15;1733:146728.

doi: 10.1016/j.brainres.2020.146728. Epub 2020 Feb 14.

 

 

2019

Hostenbach S, Pauwels A, Michiels V, Raeymaekers H, Van Binst AM, Van Merhaeghen-Wieleman A, Van Schuerbeek P, De Keyser J, D'Haeseleer M.

Trials. 2019 Mar14;20(1):164. doi: 10.1186/s13063-019-3252-4. PMID: 30871594; PMCID: PMC6416892.

Butzkueven H, Kappos L, Wiendl H, Trojano M, Spelman T, Chang I, Kasliwal R, Jaitly S,     Campbell N, Ho PR, Licata S; Tysabri Observational Program (TOP) Investigators.

J Neurol Neurosurg Psychiatry. 2020 Mar 31. pii: jnnp-2019-322326. doi: 10.1136/jnnp-2019-            322326. [Epub ahead of print]

 

D’hooghe MB*, De Cock A*, Benedict RHB, Van Remoortel A, Eelen P, D’haeseleer M, Peeters     E, De Keyser J, Nagels G. *joint first authorship

Mult Scler Relat Disord. 2019 Dec 20;39:101904. doi: 10.1016/j.msard.2019.101904. [Epub        ahead of print]

 

Gidron Y, De Couck M, Reynders T, Marechal R, Engelborghs S, D'hooghe M

J Clin Med. 2019 Dec 20;9(1). pii: E26. doi: 10.3390/jcm9010026.

 

Reynders T, Gidron Y, De Ville J, Bjerke M, Weets I, Van Remoortel A, Devolder L, D'haeseleer            M, De Keyser J, Nagels G, D’hooghe M

J Clin Med. 2019 Dec 18;9(1). pii: E3. doi: 10.3390/jcm9010003.

 

Van Schependom J, Guldolf K, D'hooghe M, Nagels G, D'haeseleer M

Transl Neurodegener. 2019 Dec 9;8:37. doi: 10.1186/s40035-019-0178-4. eCollection 2019.         Review. Erratum in: Transl Neurodegener. 2020 Jan 3;9:3.  

        

Denissen S, De Cock A, Meurrens T, Vleugels L, Van Remoortel A, Gebara B, D'Haeseleer M, D'Hooghe MB, Van Schependom J, Nagels G.

J Cent Nerv Syst Dis. 2019 Nov 6;11:1179573519884041. doi: 10.1177/1179573519884041.  eCollection 2019

 

Van Schependom J, Vidaurre D, Costers L, Sjogard M, D'Hooghe M, D'haeseleer M, Wens V, De Tiège X, Goldman S, Woolrich M, Nagels G Hum Brain Mapp 2019.

First published: 30 July 2019. https://doi.org/10.1002/hbm.24737

 

International Multiple Sclerosis Genetics Consortium. Electronic address: chris.cotsapas@yale.edu;

International Multiple Sclerosis Genetics Consortium. Cell. 2019 Jun 27;178(1):262. doi: 10.1016/j.cell.2019.06.016. 

 

Fluoxetine in Progressive Multiple Sclerosis : the FLUOX-PMS trial Cambron M, Mostert J, D'Hooghe M, Nagels G, Willekens B, Debruyne J, Algoed L, Verhagen W, Hupperts R, Heersema D, De Keyser J; FLUOX-PMS Study Group.

Mult Scler. 2019 Jun 20:1352458519843051. doi: 10.1177/1352458519843051
 

D'hooghe MB, De Cock A, Benedict RHB, Gielen J, Van Remoortel A, Eelen P, Van Merhaegen A, De Keyser J, D'haeseleer M, Peeters E, Nagels G Eur J Neurol. 2019 Jun 10. doi: 10.1111/ene.14012. [Epub ahead of print]
 

  • Single MRI-based volumetric assessment in clinical practice is associated with MS-related disability 

D'hooghe MB, Gielen J, Van Remoortel A, D'haeseleer M, Peeters E, Cambron M, De Keyser J, Nagels G.  J Magn Reson Imaging. 2019 May;49(5):1312-1321. doi: 10.1002/jmri.26303. Epub 2018 Dec 31.
 

  • Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS  

Lavie C, Rollot F, Durand-Dubief F, Marignier R, Ionescu I, Casey R, Moreau T, Tourniaire P, Hutchinson M, D’Hooghe MB, Laplaud D-A, Clavelou P, De Sèze J, Debouverie M, Brassat D, Pelletier J, Lebrun-Frenay C, Le Page E, Castelnovo G, Berger E, Hautecoeur P, Heinzlef O, Durelli L, Clerico M, Trojano M, Patti F and Vukusic S; for the PRIMS and POPARTMUS investigators Mult Scler. 2019 Apr;25(4):591-600. doi: 10.1177/1352458518763080. Epub 2018 Mar 20.
 

Hostenbach S, Pauwels A, Michiels V, Raeymaekers H, Van Binst AM, Van Merhaeghen-Wieleman A, Van Schuerbeek P, De Keyser J, D'Haeseleer M. Trials. 2019 Mar 14;20(1):164. doi: 10.1186/s13063-019-3252-4.
 

Sjøgård M, De Tiège X, Mary A, Peigneux P, Goldman S, Nagels G, van Schependom J, Quinn AJ, Woolrich MW, Wens V. Neuroimage. 2019 Jun 22;200:221-230. doi: 10.1016/j.neuroimage.2019.06.052. [Epub ahead of print]

2018

2017

  • Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop. Maria Pia Amato, Tobias Derfuss, Bernard Hemmer, Roland Liblau, Xavier Montalban, Per Soelberg Sørensen and David H Miller; For the 2016 ECTRIMS Focused Workshop Group. Multiple Sclerosis Journal 1–14 DOI: 10.1177/1352458516686847
     
  • Definition, prevalence and predictive factors of benign multiple sclerosis. Tatjana Reyndersa, Miguel D'haeseleer, Jacques De Keyser, Guy Nagels, Marie B. D'hooghe. eNeurologicalSci 7 (2017) 37–43

2016

  • Reliability of measuring regional callosal atrophy in neurodegenerative diseases. Van Schependom J, Jain S, Cambron M, Vanbinst AM, De Mey J, Smeets D, Nagels G. Neuroimage Clin. 2016 Oct 15;12:825-831. PubMed PMID: 27830115; PubMed Central PMCID: PMC5094205.
  • Self-reported levels of education and disability progression in multiple sclerosis. D'hooghe MB, Haentjens P, Van Remoortel A, De Keyser J, Nagels G. Acta Neurol Scand. 2016 Dec;134(6):414-419. doi: 10.1111/ane.12555. PubMed PMID: 27761897.
  • Measurements of brain atrophy in individual patients with multiple sclerosis. Smeets D, Ribbens A, Sima DM, Cambron M, Horakova D, Jain S, Maertens A, Van Vlierberghe E, Terzopoulos V, Van Binst AM, Vaneckova M, Krasensky J, Uher T,Seidl Z, De Keyser J, Nagels G, De Mey J, Havrdova E, Van Hecke W. Reliable Brain Behav. 2016 Jul 19;6(9):e00518. PubMed PMID: 27688944; PubMed Central PMCID: PMC5036437.
  • European Long-term Follow-up Study Group in Interferon β-1b in Secondary-progressive Multiple Sclerosis.. A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis. Kuhle J, Hardmeier M, Disanto G, Gugleta K, Ecsedi M, Lienert C, Amato MP, Baum K, Buttmann M, Bayas A, Brassat D, Brochet B, Confavreux C, Edan G, Färkkilä M, Fredrikson S, Frontoni M, D'Hooghe M, Hutchinson M, De Keyser J, Kieseier BC, KÃmpfel T, Rio J, Polman C, Roullet E, Stolz C, Vass K, Wandinger KP, Kappos L; Mult Scler. 2016 Apr;22(4):533-43. doi: 10.1177/1352458515594440. PubMed PMID: 26362898.
  • The effectiveness of a self-management occupational therapy intervention on activity performance in individuals with multiple sclerosis-related fatigue: a randomized-controlled trial.  Kos D, Duportail M, Meirte J, Meeus M, D'hooghe MB, Nagels G, Willekens B,Meurrens T, Ilsbroukx S, Nijs J. Int J Rehabil Res. 2016 Sep;39(3):255-62. doi: 10.1097/MRR.178. PubMed PMID:27182847.
  • Feasibility, Reliability and Predictive Value Of In-Ambulance Heart Rate Variability Registration. Yperzeele L, van Hooff RJ, De Smedt A, Nagels G, Hubloue I, De Keyser J, Brouns R. PLoS One. 2016 May 4;11(5):e0154834. doi:10.1371/journal.pone.0154834. PubMed PMID: 27144492; PubMed Central PMCID: PMC4856404.
  • Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine. Macdonell R, Nagels G, Laplaud DA, Pozzilli C, de Jong B, Martins da Silva A,Nicholas R, Lechner-Scott J, Gaebler JA, Agarwal S, Wang P, Yeh M, Hovenden M,Soelberg Sørensen P. Mult Scler. 2016 Jun;22(7):944-54. doi: 10.1177/1352458515606809. PubMed PMID: 26447066.
  • Assessing PML risk under immunotherapy: if all you have is a hammer, everything looks like a nail. Van Schependom J, Gielen J, Laton J, Nagels G. Mult Scler. 2016 Mar;22(3):389-92. doi: 10.1177/1352458515596458. PubMed PMID: 26199353.
  • Self-Critical Perfectionism, Dependency, and Symptomatic Distress in Patients With Personality Disorder During Hospitalization-based Psychodynamic Treatment: A Parallel Process Growth Modeling Approach. Lowyck B, Luyten P, Vermote R, Verhaest Y, Vansteelandt K. Personal Disord. 2016 May 30. [Epub ahead of print] PubMed PMID: 27244268.
  • What's in a face? Mentalizing in borderline personality disorder based on dynamically changing facial expressions. Lowyck B, Luyten P, Vanwalleghem D, Vermote R, Mayes LC, Crowley MJ. Personal Disord. 2016 Jan;7(1):72-9. doi: 10.1037/per0000144. PubMed PMID: 26461044.
  • The Construct Validity of the Dutch Personality Inventory for DSM-5 Personality Disorders (PID-5) in a Clinical Sample. Assessment. Bastiaens T, Claes L, Smits D, De Clercq B, De Fruyt F, Rossi G, Vanwalleghem D, Vermote R, Lowyck B, Claes S, De Hert M. 2016 Feb;23(1):42-51. doi: 10.1177/1073191115575069. PubMed PMID: 25736039.
  • The pathophysiological role of astrocytic endothelin-1. Hostenbach S, D'haeseleer M, Kooijman R, De Keyser J.Prog Neurobiol. 2016 Sep;144:88-102. doi: 10.1016/j.pneurobio.2016.04.009. Review. PMID:27132521

2015

  • Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes. Juryńczyk M, Weinshenker B, Akman-Demir G, Asgari N, Barnes D, Boggild M, Chaudhuri A, D'hooghe MB, Evangelou N, Geraldes R, Illes Z, Jacob A, Kim HJ, Kleiter I, Levy M, Marignier R, McGuigan C, Murray K, Nakashima I, Pandit L, Paul F, Pittock S, Selmaj K, de Sèze J, Siva A, Tanasescu R, Vukusic S, Wingerchuk D, Wren D, Leite I, Palace J. J Neurol. 2016 Jan;263(1):140-9. doi: 10.1007/s00415-015-7952-8. Epub 2015 Nov 3.
  • Do advanced statistical techniques really help in the diagnosis of the metabolic syndrome in patients treated with second-generation antipsychotics? Van Schependom J, Yu W, Gielen J, Laton J, De Keyser J, De Hert M, Nagels G. J Clin Psychiatry. 2015 Oct;76(10):e1292-9. doi: 10.4088/JCP.14m09367.
  • Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine.  Macdonell R, Nagels G, Laplaud DA, Pozzilli C, de Jong B, Martins da Silva A, Nicholas R,  Lechner-Scott J, Gaebler JA, Agarwal S, Wang P, Yeh M, Hovenden M, Soelberg Sørensen P. Mult Scler. 2015 Oct 7. pii: 1352458515606809.
  • Risk Knowledge in Relapsing Multiple Sclerosis (RIKNO 1.0)--Development of an Outcome Instrument for Educational Interventions. Heesen C, Kasper J, Fischer K, Köpke S, Rahn A, Backhus I, Poettgen J, Vahter L, Drulovic J, Van Nunen A, Beckmann Y, Liethmann K, Giordano A, Fulcher G, Solari A; AutoMS-group. PLoS One. 2015 Oct 2;10(10):e0138364. doi: 10.1371/journal.pone.0138364. eCollection 2015.
  • A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis. Kuhle J, Hardmeier M, Disanto G, Gugleta K, Ecsedi M, Lienert C, Amato MP, Baum K, Buttmann M, Bayas A, Brassat D, Brochet B, Confavreux C, Edan G, Färkkilä M, Fredrikson S, Frontoni M, D'hooghe MB, Hutchinson M, De Keyser J, Kieseier BC, Kümpfel T, Rio J, Polman C, Roullet E, Stolz C, Vass K, Wandinger KP, Kappos L.; European Long-term Follow-up Study Group in Interferon β-1b in Secondary-progressive Multiple Sclerosis. Mult Scler. 2016 Apr;22(4):533-43. doi: 10.1177/1352458515594440. Epub 2015 Sep 11. PMID: 26362898
  • Neurological patients and their lower limb orthotics: An observational pilot study about acceptance and satisfaction. Swinnen E, Lafosse C, Van Nieuwenhoven J, Ilsbroukx S, Beckwée D, Kerckhofs E. Prosthet Orthot Int. 2015 Aug 5. pii: 0309364615592696. PMID: 26246356
  • Heart rate variability and baroreceptor sensitivity in acute stroke: a systematic review. Yperzeele L, van Hooff RJ, Nagels G, De Smedt A, De Keyser J, Brouns R. Int J Stroke. 2015 Aug;10(6):796-800. doi: 10.1111/ijs.12573. Review. PMID: 26202709
  • Assessing PML risk under immunotherapy: if all you have is a hammer, everything looks like a nail. Van Schependom J, Gielen J, Laton J, Nagels G. Mult Scler. 2016 Mar;22(3):389-92. doi: 10.1177/1352458515596458. Epub 2015 Jul 21. PMID: 26199353
  • Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis? D'Haeseleer M, Hostenbach S, Peeters I, Sankari SE, Nagels G, De Keyser J, D'hooghe MB. J Cereb Blood Flow Metab. 2015 Sep;35(9):1406-10. doi: 10.1038/jcbfm.2015.131. Epub 2015 Jun 24. Review.
  • The Arm Function in Multiple Sclerosis Questionnaire (AMSQ): development and validation of a new tool using IRT methods. Mokkink LB, Knol DL, van der Linden FH, Sonder JM, D'hooghe MB, Uitdehaag BM. Disabil Rehabil. 2015 Jul 26:1-7.
  • "How to conquer a mountain with multiple sclerosis". How a climbing expedition to Machu Picchu affects the way people with multiple sclerosis experience their body and identity: a phenomenological analysis. Calsius J, Courtois I, Feys P, Van Asch P, De Bie J, D'hooghe MB. Disabil Rehabil. 2015 Jul 2:1-7.
  • The Construct Validity of the Dutch Personality Inventory for DSM-5 Personality Disorders (PID-5) in a Clinical Sample. Bastiaens T, Claes L, Smits D, De Clercq B, De Fruyt F, Rossi G, Vanwalleghem D, Vermote R, Lowyck B, Claes S, De Hert M. Assessment. 2016 Feb;23(1):42-51.
  • Music therapy and depression. Van Assche E, De Backer J, Vermote R. Tijdschr Psychiatr. 2015;57(11):823-9. Dutch.
  • What's in a face? Mentalizing in borderline personality disorder based on dynamically changing facial expressions. Lowyck B, Luyten P, Vanwalleghem D, Vermote R, Mayes LC, Crowley MJ. Personal Disord. 2016 Jan;7(1):72-9. doi: 10.1037/per0000144. Epub 2015 Oct 12.
  • A psychoanalytically informed hospitalization-based treatment of personality disorders. Vermote R, Luyten P, Verhaest Y, Vandeneede B, Vertommen H, Lowyck B. Int J Psychoanal. 2015 Jun;96(3):817-43. doi: 10.1111/1745-8315.12394. PMID: 26173889